Clinical Application of Radioimmunoguided Surgery in Colorectal Cancer Using 125I-Labeled Carcinoembryonic Antigen-Specific Monoclonal Antibody Submucosally

Diseases of the Colon and Rectum

Volumn 46, Issue 12, 2003, Pages 1659-1666

  Gu, Jin ^a   Zhao, Jun ^a   Li, Zhenfu ^a   Yang, Zhi ^a   Zhang, Jichang ^a   Gao, Zhian ^a   Wang, Yi ^a   Xu, Guangwei ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Colorectal cancer; Monoclonal antibody; Radioimmunoguided surgery

Indexed keywords

CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; CL 58; IMMUNOGLOBULIN G1; IODINE 125;

ADULT; AGED; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; RADIOIMMUNOGUIDED SURGERY;

EID: 0348042077     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02660772     Document Type: Article

References (17)

1. Zhen S. Recent study on colorectal cancer in China: early detection and novel related gene. Chin Med J 1998;110:309-10.
2. Muxi A, Pons F, Vidal-Sicart S, et al. Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody. Nucl Med Commun 1999;20:123-30.
3. Kotanagi H, Fukuoka T, Shibata Y, et al. The size of regional lymph nodes dose not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer. J Surg Oncol 1993;54:252-4.
4. Mayer A, Tsiompanou E, Denise O, et al. Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody. Clin Cancer Res 2000;6:1711-9.
5. Haddad R, Avital S, Troitsa A, et al. Benefits of radioimmunoguided surgery for pelvic recurrence. Eur J Surg Oncol 2001;27:298-301.
6. Bakalakos EA, Young DC, Martin EW Jr, et al. Radioimmunoguided surgery for patients with liver metastases secondary to colorectal cancer. Ann Surg Oncol 1998; 5:590-4.
7. Stramignoni D, Bowen R, Atkinson B F, et al: Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. Int J Cancer 1983;31:542-52.
8. Kim JC, Kim WS, Ryu JS, et al. Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma. Cancer Res 2000;60:4825-9.
9. Lin BH, Yang Z, Zhang MY, et al. Preliminary study of RIS in 26 cancer patients. Chinese J Nucl Med 1997;17: 116.
10. Xu G, Zhang M, Liu B, et al. Radioimmunoguided surgery in gastric cancer using 131I labeled monoclonal antibody 3H11. Semin Surg Oncol 1994;10:88-94.
11. Yang Z, Li Z, Zhang M, et al. Study of 99mTc/188Re labeled anti-CEA MAb CL58 and its biodistribution. Chin J Nucl Med 2000;20:228-9.
12. Obuchowski NA. On the comparison of correlated proportions for clustered data. Stat Med 1998;17: 1495-507.
13. Percivale P, Bertoglio S, Meszaros P, et al. Radioimmunoguided surgery with different iodine-125 radiolabeled monoclonal antibodies in recurrent colorectal cancer. Semin Surg Oncol 1998;15:231-4.
14. Nieroda CA, Mojzisik C, Sardi A, et al. The impact of radioimmunoguided surgery (RIGS™) on surgical decision-making in colorectal cancer. Dis Colon Rectum 1989;32:927-32.
15. Zhao HY. Nuclear medicine. Shanghai publishing company of scientific technology 1979:127.
16. Deguchi T, Doi T, Ehara H, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993;53:5350-4.
17. Hayashi N, Arakawa H, Nagase H, et al. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res 1994; 54:3853-6.